“At Servier, we are resolutely focused on tackling the challenges of therapeutic innovation.”
President of Servier
2021/2022 Integrated Annual Report
2021/2022 Integrated Annual Report
For the first time, Servier is publishing an Integrated Annual Report
In 2022, we launched our 2030 Ambition, which is set out in this report. This document illustrates Servier’s strategic vision, as well as its significant impact in society regarding the way it benefits patients and makes the world more sustainable.
EDITORIAL
Integrated Annual Report
Ambition for 2030
At Servier, we draw strength from our independence.
As we are free to make our own strategic decisions and adopt a long-term vision, we are able to fulfill our vocation as a Group committed to therapeutic progress to serve patient needs.
Integrated Annual Report
Our presence throughout the world
Our medicines treat patients in over 150 countries.
2021/2022 Dashboard
4.9
€4.9 bn consolidated sales revenue at September 30, 2022
> 20%
Share of revenue from brand-name medicines invested in R&D each year
21,400
Employee headcount at September 30, 2022
4.23/5
Overall engagement score among Servier Group employees in 2022
-7.7 %
Year-on-year reduction in scope 1 and 2 greenhouse gas emissions
